On October 9, 2026, Immunic is trading 5.6% higher at $7.98, with no confirmed catalyst identified for the intraday gain. - Its October 7 release announced accepted abstracts for a Toronto multiple-sclerosis meeting later in October; available reporting does not link the news to the move. - Biotech was down 2.04%, while major indices were modestly higher; neither provides a direct explanation.